Conceptio › Archive › HAL (France)
HAL (France)open access

Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trial

Stefano Kim et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
2, 1, 0
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 322471
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.